MICHAEL ASBACH: Open Payments
NPI 1699030411 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296,343 in 674 payments from 25 companies in 2025. Trend: 2023 $194,833 · 2024 $225,855 · 2025 $296,343
Speaker / faculty: $146,710Honoraria: $66,238Consulting: $46,896Travel & lodging: $24,255Food & beverage: $12,189Education: $55
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 114 | $71,766 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 117 | $61,084 |
| Janssen Pharmaceuticals, Inc | 94 | $56,718 |
| E.R. Squibb & Sons, L.L.C. | 80 | $56,339 |
| Neurocrine BioSciences, Inc. | 67 | $26,186 |
| Teva Pharmaceuticals USA, Inc. | 45 | $13,536 |
| Otsuka America Pharmaceutical, Inc. | 51 | $7,797 |
| Janssen Scientific Affairs, LLC | 11 | $1,528 |
| Alkermes, Inc. | 18 | $289 |
| Lundbeck LLC | 21 | $277 |
Products named: Auvelity, CAPLYTA, SPRAVATO, INGREZZA, COBENFY, UZEDY, REXULTI, ARISTADA.
Industry payments across NY — which companies pay providers there.
